ici 118551 has been researched along with Colorectal Cancer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, H; Lin, Q; Wang, F; Yang, R; Zhang, P; Zheng, X | 1 |
Coelho, M; Correia, G; Medeiros, R; Moz, M; Ribeiro, L; Teixeira, A | 1 |
Cheng, CC; Chin, CC; Huang, YC; Kuo, YH; Lai, HC; Lee, KF; Li, JM; Shi, CS; Wang, KC | 1 |
3 other study(ies) available for ici 118551 and Colorectal Cancer
Article | Year |
---|---|
Effect of chronic restraint stress on human colorectal carcinoma growth in mice.
Topics: Adrenergic Antagonists; Animals; Atenolol; Cell Proliferation; Colorectal Neoplasms; Epinephrine; Gene Expression; Humans; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Transplantation; Norepinephrine; Phentolamine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Restraint, Physical; Stress, Physiological; Tumor Burden; Tumor Cells, Cultured | 2013 |
Antiproliferative effects of β-blockers on human colorectal cancer cells.
Topics: Adenocarcinoma; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Atenolol; Carbazoles; Carvedilol; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Epinephrine; HT29 Cells; Humans; Isoproterenol; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Signal Transduction | 2015 |
Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Animals; Apoptosis; Atenolol; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cytochromes c; ErbB Receptors; G1 Phase Cell Cycle Checkpoints; Gene Expression; HCT116 Cells; HT29 Cells; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Propanolamines; Propranolol; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Receptors, Adrenergic, beta; Signal Transduction; Xenograft Model Antitumor Assays | 2016 |